Intern, IS R&D Business Platforms

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

Requirements

• Pursuing a bachelor’s degree in a STEM field
• Strong analytical, and critical-thinking, and problem-solving skills
• Ability to synthesize complex information into clear, concise explanations
• Strong written and verbal communication skills
• Interest in working with cross-functional teams across IT, QA and R&D teams
• Organized, detail-oriented, and able to work independently with guidance
• Professional curiosity and willingness to learn new concepts
• Core regulatory concepts such as data integrity (e.g. ALCOA+), system fit-for-intended-use etc.

Benefits

• Competitive cash compensation
• Robust equity awards
• Strong benefits
• Significant learning and development opportunities